Related Experiment Video
Updated: Jan 3, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
SNHG16 promotes the progression of osteoarthritis through activating microRNA-93-5p/CCND1 axis
1Department of Orthopedics, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. liudan5900@163.com.
Objective:
This study aims to investigate whether SNHG16 (small nucleolar RNA host gene 16) can promote the progression of osteoarthritis (OA) by regulating the microRNA-93-5p/Cyclin D1 (CCND1) axis, thereby finding new therapeutic targets for the treatment of OA.
Patients And Methods:
A total of 23 OA patients and 23 patients undergoing lower extremity amputation were enrolled in this study. We collected their cartilage tissues from knee joint for isolating chondrocytes. The relative levels of SNHG16, CCND1 and microRNA-93-5p in cartilage tissues of OA patients and controls were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The regulatory effect of SNHG16 on proliferative potential of chondrocytes was evaluated by Cell Counting Kit-8 (CCK-8) and colony formation assay, respectively. Cell cycle progression was examined using flow cytometry. Dual-Luciferase reporter gene assay was conducted to verify the binding between SNHG16 with microRNA-93-5p and microRNA-93-5p with CCND1. Rescue experiments were performed to elucidate whether SNHG16 regulated CCND1 expression by targeting microRNA-93-5p.
Results:
The expressions of SNHG16 and CCND1 upregulated, while microRNA-93-5p downregulated in cartilage tissues of OA patients relative to controls. Correlation regression analyses showed a negative expression correlation between SNHG16 and microRNA-93-5p, as well as CCND1 and microRNA-93-5p in OA patients. On the contrary, SNHG16 expression was positively correlated to CCND1 expression in OA. The knockdown of SNHG16 suppressed viability, cloning ability and cell cycle progression, but induced apoptosis in chondrocytes. Dual-Luciferase reporter gene assay showed that SNHG16 could bind to microRNA-93-5p. SNHG16 knockdown markedly upregulated the expression of microRNA-93-5p. Moreover, the knockdown of microRNA-93-5p reversed the inhibited viability due to SNHG16 knockdown. Transfection of microRNA-93-5p mimics markedly inhibited CCND1 expression. Importantly, CCND1 overexpression reversed the inhibitory effect of SNHG16 knockdown on chondrocyte viability.
Conclusions:
SNHG16 promotes the development of OA by regulating microRNA-93-5p/CCND1 axis.
Insights
Small nucleolar RNA host gene 16 (SNHG16) promotes osteoarthritis (OA) by upregulating Cyclin D1 (CCND1) via downregulating microRNA-93-5p. This highlights SNHG16 as a potential therapeutic target for OA treatment.
Area of Science:
- Molecular Biology
- Biochemistry
- Orthopedics
Background:
- Osteoarthritis (OA) is a degenerative joint disease with limited therapeutic options.
- Understanding the molecular mechanisms driving OA progression is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of small nucleolar RNA host gene 16 (SNHG16) in OA pathogenesis.
- To determine if SNHG16 promotes OA by regulating the microRNA-93-5p/Cyclin D1 (CCND1) axis.
- To identify SNHG16 as a potential therapeutic target for OA.
Main Methods:
- Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to measure gene expression in OA and control cartilage tissues.
- Cell Counting Kit-8 (CCK-8), colony formation assay, and flow cytometry to assess chondrocyte proliferation and cell cycle.
- Dual-Luciferase reporter gene assay to confirm molecular interactions.
- Rescue experiments to validate the regulatory pathway.
Main Results:
- SNHG16 and CCND1 were upregulated, while microRNA-93-5p was downregulated in OA cartilage.
- SNHG16 knockdown inhibited chondrocyte viability, proliferation, and cell cycle progression.
- SNHG16 directly targets microRNA-93-5p, and microRNA-93-5p targets CCND1.
- SNHG16 promotes OA development by upregulating CCND1 through the suppression of microRNA-93-5p.
Conclusions:
- SNHG16 plays a critical role in promoting osteoarthritis development.
- The SNHG16/microRNA-93-5p/CCND1 axis is a key pathway in OA pathogenesis.
- Targeting SNHG16 offers a promising therapeutic strategy for osteoarthritis.
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
The JAK-STAT Signaling Pathway
Osteoclasts in Bone Remodeling
